SS
ORIC icon

SBI Securities’s Oric Pharmaceuticals ORIC Stock Holding History

SBI Securities’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22 Hold
2
– – ﹤0.01% 3830
2026
Q1 		$25 Hold
2
– – ﹤0.01% 3727
2025
Q4 		$16 Sell
2
-1
-33% -$12 ﹤0.01% 3814
2025
Q3 		$36 Buy
3
+1
+50% +$11 ﹤0.01% 3798
2025
Q2 		$20 Hold
2
– – ﹤0.01% 3916
2025
Q1 		$11 Hold
2
– – ﹤0.01% 3955
2024
Q4 		$16 Buy
+2
New +$18 ﹤0.01% 3873

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities's ORIC Position: Q2 2026 in Review

SBI Securities held its Oric Pharmaceuticals (ORIC) position steady in Q2 2026 at 2 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #3830.

SBI Securities first reported a position in ORIC in Q4 2024 and has held it in 7 quarters since. The position peaked at $36 in Q3 2025. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • SBI Securities held 2 shares of Oric Pharmaceuticals worth $22 as of Q2 2026.
  • SBI Securities left its Oric Pharmaceuticals share count unchanged in Q2 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3830 holding.
  • SBI Securities first reported a position in Oric Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Oric Pharmaceuticals position peaked at $36 in Q3 2025.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.